{"disease":{"id":"botulism","name":"botulism"},"drugs":{"marketed":[{"drug_id":"penicillin-g-sodium","indication_name":"Botulism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PENICILLIN G SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03658902","title":"Retrospective Epidemiological Study on Botulism in Intensive Care Units in France","phase":"","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Centre Hospitalier le Mans","has_results":false},{"nct_id":"NCT03676634","title":"Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG®","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"California Department of Public Health","has_results":true},{"nct_id":"NCT06112834","title":"Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG®","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"California Department of Public Health","has_results":false},{"nct_id":"NCT03603665","title":"A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02779140","title":"Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05769478","title":"Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}